Razelle Kurzrock: Privileged to honor 2 visionaries a few years ago
Razelle Kurzrock, Founding Director of Michels Rare Cancers Research Laboratories at Medical College of Wisconsin, shared a post on X:
“I was privileged to honor 2 visionaries a few years ago.
John Mendelsohn, President, MD Anderson inspired personalized cancer medicine.
Waun Ki Hong, Chair Medicine, asked me to found phase I agnostic department.
His one demand was that it be best in world.”
Razelle Kurzrock, MD, is a world-renowned physician-scientist leader in precision medicine as well as in the development of novel therapeutics in the field of oncology. She is recognized for founding, developing and chairing one of the largest Phase 1 clinical trial departments globally while at the University of Texas MD Anderson Cancer Center; the central theme of the department was a personalized medicine strategy. She is also one of the pioneering trialists of the WINTHER precision medicine international trial focusing, for the first time, on transcriptomics in addition to genomics. This trial was the signature study of the Worldwide Innovative Network (WIN) consortium (Nature Medicine). She also developed and led some of the first tumor-agnostic cancer clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023